• Earlier this week, Rocket Lab Corporation announced it had secured its largest launch contract to date, a US$266 million multi-launch agreement with the U.S. Space Force for at least 12 suborbital missions supporting missile defense tests, primarily flying from a new site at the Pacific Spaceport Complex-Alaska.
• This contract deepens Rocket Lab’s role as an end-to-end provider for U.S. national security space programs, adding multi-year revenue visibility and expanding its geographic launch footprint across New Zealand, Virginia, and Alaska.
• We’ll now examine how this record U.S. Space Force contract, and the added revenue visibility it brings, affects Rocket Lab’s investment narrative.

Invest in the nuclear renaissance through our list of 90 elite nuclear energy infrastructure plays powering the global AI revolution.

Rocket Lab Investment Narrative Recap

To own Rocket Lab today, you need to believe it can turn its expanding government and commercial space footprint into lasting revenue and, eventually, profits, despite ongoing losses and heavy Neutron and M&A spending. The new US$266 million U.S. Space Force contract adds multi‑year backlog and helps address the “lumpiness” risk around large program wins, but it does not remove the near term pressure from high capital needs, potential dilution, and execution risk on Neutron and the Iridium acquisition.

The most directly relevant recent development is Rocket Lab’s VICTUS HAZE rapid response mission for the U.S. Space Force, where it supplied the rocket, spacecraft, software, and operations as a single prime contractor. Together with the new multi‑launch Space Force deal, this reinforces Rocket Lab’s pitch as an integrated national security partner, which could support its key catalyst of converting government interest into recurring, higher margin programs across launch and space systems.

Yet investors should also weigh how this bigger U.S. Space Force win interacts with Rocket Lab’s elevated cash burn, rising capital needs, and the possibility of further dilution that investors should be aware of...

Rocket Lab’s narrative projects $1.8 billion revenue and $169.1 million earnings by 2029. This requires 37.6% yearly revenue growth and an earnings increase of about $352 million from -$182.6 million today.

Uncover how Rocket Lab's forecasts yield a $114.33 fair value, a 95% upside to its current price.

Exploring Other Perspectives

Some of the lowest analysts take a much more cautious view, even before this news, assuming revenue reaches about US$1.7 billion and earnings only US$14.8 million by 2029, and worrying that higher capital intensity and integration risk could cap margins, so you should recognize how widely views can differ and consider how this new Space Force contract might shift both the optimistic and the pessimistic narratives.

Explore 31 other fair value estimates on Rocket Lab - why the stock might be worth over 2x more than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Rocket Lab research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Rocket Lab research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Rocket Lab's overall financial health at a glance.

Contemplating Other Strategies?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• We've uncovered the 9 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
• The future of work is here. Discover the 34 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.